The Pfizer papers; Biogen layoffs begin; AbbVie inks a buyout; GSK makes Slaoui pay; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We are saddened this week to say goodbye to our managing editor, Kyle Blankenship, as he begins a new chapter in his career. But we are equally grateful for the time together and excited about the team he’s helped shape.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,400+ biopharma pros reading Endpoints daily — and it's free.